Verified peer comparison
iSpecimen vs Lakewood-Amedex Biotherapeutics Financial Comparison
Direct answer
iSpecimen and Lakewood-Amedex Biotherapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free iSpecimen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- iSpecimen Revenue
- 1,928,998 USD
- Lakewood-Amedex Biotherapeutics Revenue
- 0 USD
- iSpecimen Operating income
- -8,977,919 USD
- Lakewood-Amedex Biotherapeutics Operating income
- -3,772,370 USD